The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis
- PMID: 15296100
The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis
Abstract
This study presents the efficiency of the experimental antifungal agents 6-amino-2-n-pentylthiobenzothiazole (APB) and the echinocandin micafungin, and amphotericin B against fluconazole-resistant Candida albicans and Candida dubliniensis (MIC95 for fluconazole > 64 mg/l). The benzothiazole APB was less active against C. albicans and C. dubliniensis (MIC80 = 8 - 32 mg/l, MIC95 = 16 - 64 mg/l) than amphotericin B, which was efficient in a concentration range from 0.125 to 2 mg/l. However, the efficiency of micafungin was very high with MIC80, and MIC100 < or = 0.031 mg/l.
Similar articles
-
Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.J Clin Microbiol. 2006 Feb;44(2):324-6. doi: 10.1128/JCM.44.2.324-326.2006. J Clin Microbiol. 2006. PMID: 16455878 Free PMC article.
-
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.J Antimicrob Chemother. 2004 Feb;53(2):283-9. doi: 10.1093/jac/dkh053. Epub 2003 Dec 19. J Antimicrob Chemother. 2004. PMID: 14688039
-
In vitro interaction of micafungin and fluconazole against Candida.J Antimicrob Chemother. 2007 Jul;60(1):188-90. doi: 10.1093/jac/dkm177. Epub 2007 May 24. J Antimicrob Chemother. 2007. PMID: 17525050 No abstract available.
-
Micafungin: a new echinocandin.Clin Infect Dis. 2006 Apr 15;42(8):1171-8. doi: 10.1086/501020. Epub 2006 Mar 14. Clin Infect Dis. 2006. PMID: 16575738 Review.
-
Micafungin: a new echinocandin antifungal.Pharmacotherapy. 2007 Jan;27(1):53-67. doi: 10.1592/phco.27.1.53. Pharmacotherapy. 2007. PMID: 17192162 Review.
Cited by
-
Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients.Paediatr Drugs. 2009;11(4):271-91. doi: 10.2165/00148581-200911040-00006. Paediatr Drugs. 2009. PMID: 19566111 Review.
-
The impact of growth conditions on biofilm formation and the cell surface hydrophobicity in fluconazole susceptible and tolerant Candida albicans.Folia Microbiol (Praha). 2015 Jan;60(1):45-51. doi: 10.1007/s12223-014-0338-y. Epub 2014 Aug 7. Folia Microbiol (Praha). 2015. PMID: 25100641
-
Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections.Drugs. 2008;68(15):2225-55. doi: 10.2165/00003495-200868150-00010. Drugs. 2008. PMID: 18840009 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials